MW

Mark Waer

KR Katholieke Universiteit Leuven, Ku Leuven R&D: 3 patents #48 of 512Top 10%
AG Aventis Pharma Deutschland Gmbh: 2 patents #137 of 418Top 35%
KD K.U. Leuven Research & Development: 2 patents #29 of 174Top 20%
📍 Heverlee, BE: #30 of 285 inventorsTop 15%
Overall (All Time): #512,390 of 4,157,543Top 15%
10
Patents All Time

Issued Patents All Time

Showing 1–10 of 10 patents

Patent #TitleCo-InventorsDate
9301961 Autoimmune and inflammatory disorder therapy Jean Herman, Thierry Louat, Qiuya Huang, Bart Vanderhoydonck, Piet Herdewijn 2016-04-05
9221822 Thiazolopyrimidine modulators as immunosuppressive agents Piet Herdewijn, Steven De Jonghe, Ling-Jie Gao, Mi Yeon Jang, Bart Vanderhoydonck +3 more 2015-12-29
8901132 Thiazolopyrimidine modulators as immunosuppressive agents Piet Herdewijn, Steven De Jonghe, Ling-Jie Gao, Mi Yeon Jang, Bart Vanderhoydonck +3 more 2014-12-02
7501513 Immunosuppressive effects of pteridine derivatives Piet Herdewijn, Wolfgang Pfleiderer, Arnaud Marchand, Steven De Jonghe 2009-03-10
7276506 Immunosuppressive effects of pteridine derivatives Piet Herdewijn, Wolfgang Pfleiderer 2007-10-02
7253176 Immunosuppressive effects of 8-substituted xanthine derivatives Piet Herdewijn, Wolfgang Pfleiderer 2007-08-07
6946465 Immunosuppressive effects of pteridine derivatives Piet Herdewijn, Wolfgang Pfleiderer 2005-09-20
6432968 Combination preparation, containing cyclosporin a or FK506 or rapamycin and a xanthine derivative Martin Schönharting, Ulrich Gebert 2002-08-13
6046328 Combination preparation, containing cyclosporin A or FK506 or rapamycin and a xanthine derivative Martin Schönharting, Ulrich Gebert 2000-04-04
5665387 Methods and compositions for primary and secondary prevention of autoimmune diabetes Chantal Mathieu, Roger Bouillon 1997-09-09